Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193,980 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Progress on clinical trials of cancer drugs in China, 2019].
Huang HY, Wu DW, Wang HX, Wang J, Fan Q, Wang SH, Bai Y, Yu Y, Fang Y, Sun C, Fang H, Bai H, Wang X, Liu ZY, Jiang M, Liu Z, Wang XH, Li HY, Li N, Cao C, Xu BH, Sun Y, He J. Huang HY, et al. Among authors: wang x, wang hx, wang xh, wang j, wang sh. Zhonghua Zhong Liu Za Zhi. 2020 Feb 23;42(2):127-132. doi: 10.3760/cma.j.issn.0253-3766.2020.02.008. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 32135647 Chinese.
[Efficacy and safety of neoadjuvant apatinib in combination with dose-dense paclitaxel and carboplatin in locally advanced triple negative breast cancer patients].
Ou KP, Li Q, Luo Y, Lyu JJ, Zhou H, Yang Y, Cai YJ, Wang ZJ, Wang X, Qi LQ, Ma F, Xu BH. Ou KP, et al. Among authors: wang x, wang zj. Zhonghua Zhong Liu Za Zhi. 2020 Nov 23;42(11):966-971. doi: 10.3760/cma.j.cn112152-20200224-00122. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 33256310 Clinical Trial. Chinese.
[Progress on clinical trials of cancer drugs in China, 2020].
Wu DW, Huang HY, Tang Y, Wang HX, Wang J, Wang SH, Fang H, Yang XY, Li J, Wang X, Liu LJ, Yan Y, Wang Q, Li N, Cao C, Xu BH, Sun Y, He J. Wu DW, et al. Among authors: wang x, wang hx, wang j, wang sh, wang q. Zhonghua Zhong Liu Za Zhi. 2021 Feb 23;43(2):218-223. doi: 10.3760/cma.j.cn112152-20201221-01089. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 33601488 Chinese.
[Correlation between nUGT1A1 gene polymorphisms and adverse events of irinotecan plus S-1 for patients with recurrent or metastatic esophageal squamous cell carcinoma: a prospective, open-label, randomized controlled trial (ESWN 01)].
Wang X, Liu Y, Huang JX, Lu P, Ba Y, Wu L, Bai YX, Zhang S, Feng JF, Cheng Y, Li J, Wen L, Yuan XL, Ma CW, Hu CH, Fan QX, Xu BH, Huang J. Wang X, et al. Zhonghua Zhong Liu Za Zhi. 2021 Nov 23;43(11):1177-1182. doi: 10.3760/cma.j.cn112152-20191022-00678. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34794220 Clinical Trial. Chinese.
[Progress on clinical trials of common gastrointestinal cancer drugs in China from 2012 to 2021].
Huang HY, Wu DW, Zhu Q, Yu Y, Wang HX, Wang J, Ga M, Meng XY, Du JT, Miao SM, Zhao ZX, Wang X, Shang P, Guo MJ, Liu LH, Tang Y, Li N, Cao C, Xu BH, Sun Y, He J. Huang HY, et al. Among authors: wang x, wang hx, wang j. Zhonghua Zhong Liu Za Zhi. 2022 Mar 23;44(3):276-281. doi: 10.3760/cma.j.cn112152-20211207-00907. Zhonghua Zhong Liu Za Zhi. 2022. PMID: 35316878 Chinese.
[Consensus of experts on the medical risk prevention for the patients with cardiovascular diseases during dental treatment (2022 edition)].
Zhang J, Su GH, Zhang XD, Xu K, Wang ZM, Deng XL, Zhu YQ, Chen YJ, Gao CZ, Xie H, Pan X, Yin L, Xu BH, Fei W, Zhou J, Shao D, Zhang ZH, Zhang K, Wang X, Cheng X, Wang X, Chen LL. Zhang J, et al. Among authors: wang x, wang zm. Zhonghua Kou Qiang Yi Xue Za Zhi. 2022 May 9;57(5):462-473. doi: 10.3760/cma.j.cn112144-20220311-00102. Zhonghua Kou Qiang Yi Xue Za Zhi. 2022. PMID: 35484668 Chinese.
193,980 results
You have reached the last available page of results. Please see the User Guide for more information.